NASDAQ:SXTP | Income Statement | 60 DEGREES PHARMACEUTICALS, INC.

Complete source-backed income-statement history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$207,898.00$151,100.00$56,798.00$598,653.00$2.33M-$2.27M-$2.27M-$2.26M-$0.90-$0.902,653,8482,653,848
2026-03-31$162,092.00$85,715.00$76,377.00$281,464.00$2.17M-$2.09M-$2.09M-$2.09M-$1.28-$1.281,725,7581,725,758
2025-12-31$303,385.00$120,682.00$182,703.00$638,873.00$2.11M-$1.92M-$1.44M-$1,813.00-$1.44M-$8.81-$7.08-1,482,471181,557
2025-09-30$437,602.00$537,690.00-$100,088.00$809,777.00$2.32M-$2.33M-$2.32M$250.00-$2.32M-$0.66-$0.663,675,4073,675,407
2025-06-30$100,932.00$50,051.00$50,881.00$231,912.00$1.86M-$1.61M-$1.73M$1,500.00-$1.73M-$5.01-$5.01368,250368,250
2025-03-31$163,552.00$73,272.00$90,280.00$370,813.00$2.09M-$1.91M-$1.88M$63.00-$1.88M-$6.25-$6.25320,890320,890
2024-12-31$241,635.00$118,077.00$123,558.00$613,955.00$2.22M-$2.07M-$2.05M-$751.00-$2.05M-$52.43-$52.43-173,864-173,864
2024-09-30$135,293.00$111,687.00$23,606.00$940,063.00$2.16M-$2.12M-$2.16M$250.00-$2.16M-$4.65-$2.92488,6542,152,682
2024-06-30$124,972.00$89,564.00$35,408.00$3.1M$4.22M-$4.19M-$4.17M$438.00-$4.17M-$21.12-$21.12202,967202,967
2024-03-31$105,674.00$65,437.00$40,237.00$337,182.00$1.41M-$1.34M$428,048.00$63.00$430,470.00$1.83$1.83168,756168,756
2023-12-31$125,681.00$146,257.00-$20,576.00$100,201.00$1.79M-$1.89M-$2.05M$61.00-$2.01M-$52.59-$52.59-214,077-214,077
2023-09-30$51,188.00$71,196.00-$20,008.00$263,703.00$1.58M-$1.52M$4.17M$63.00$4.18M$9.13$9.13448,174448,174
2023-06-30$59,532.00$183,977.00-$124,445.00$203,872.00$666,667.00-$787,996.00-$3.34M$63.00-$3.34M-$16.84-$16.84198,170198,170
2023-03-31$17,172.00$73,120.00-$55,948.00$123,994.00$899,008.00-$950,664.00-$2.6M$63.00-$2.6M-$1.13-$1.132,304,1312,304,131
2022-12-31-$37,174.00$162,835.00$203,457.00$513,022.00-$684,698.00-$1.67M-$250.00-$1.68M-$0.69-$0.696,1606,160
2022-09-30$168,185.00$92,281.00$27,655.00$441,282.00-$215,116.00-$1.45M$250.00-$1.45M-$0.61-$0.612,386,0092,386,009
2022-06-30$45,173.00$87,120.00$231,394.00$637,232.00-$686,919.00-$2.15M$250.00-$2.15M-$0.96-$0.962,349,3492,349,349
2022-03-31-$907,447.00

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.01M$781,695.00$223,776.00$2.11M$8.39M-$7.76M$390,254.00-$7.37M$0.00-$7.37M-$11.73-$11.73670,211670,211
2024-12-31$607,574.00$384,765.00$222,809.00$4.99M$10.01M-$9.72M$1.76M-$7.96M$0.00-$7.95M-$74.17-$74.17113,665113,665
2023-12-31$253,573.00$474,550.00-$220,977.00$691,770.00$4.93M-$5.15M-$3.81M$250.00-$3.77M-$59.18-$59.1866,31466,314
2022-12-31$223,208.00$432,370.00-$209,162.00$525,563.00$1.83M-$1.75M-$6.18M$500.00-$6.18M-$2.61-$2.612,367,7292,367,729

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.